These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 9059819

  • 1. Screening for renal carcinoma associated mutations in the von Hippel-Lindau tumor suppressor gene by temperature gradient gel electrophoresis.
    Wenzel M, Enczmann J, Uhrberg M, Hernández A, Wiese U, Ackermann R, Schmitz-Draeger B, Ebert T, Wernet P.
    Electrophoresis; 1997 Jan; 18(1):45-51. PubMed ID: 9059819
    [Abstract] [Full Text] [Related]

  • 2. Establishment of experimental conditions for the rapid detection of mutations in the von Hippel-Lindau gene by parallel temperature gradient gel electrophoresis.
    Hernández A, Meyer A, Enczmann J, Ackermann R, Wernet P.
    Electrophoresis; 1999 Jul; 20(10):1958-61. PubMed ID: 10451103
    [Abstract] [Full Text] [Related]

  • 3. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
    Zhuang Z, Gnarra JR, Dudley CF, Zbar B, Linehan WM, Lubensky IA.
    Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
    [Abstract] [Full Text] [Related]

  • 4. Mutations of the VHL tumour suppressor gene in renal carcinoma.
    Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM.
    Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
    [Abstract] [Full Text] [Related]

  • 5. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
    Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B.
    Cancer Res; 1994 Jun 01; 54(11):2852-5. PubMed ID: 8187067
    [Abstract] [Full Text] [Related]

  • 6. Molecular genetic studies of sporadic and familial renal cell carcinoma.
    Gnarra JR, Glenn GM, Latif F, Anglard P, Lerman MI, Zbar B, Linehan WM.
    Urol Clin North Am; 1993 May 01; 20(2):207-16. PubMed ID: 8098558
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis.
    Cario H, Schwarz K, Jorch N, Kyank U, Petrides PE, Schneider DT, Uhle R, Debatin KM, Kohne E.
    Haematologica; 2005 Jan 01; 90(1):19-24. PubMed ID: 15642664
    [Abstract] [Full Text] [Related]

  • 11. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL, Ghadimi BM, Wangsa D, Padilla-Nash H, Worrell R, Hewitt S, Walther M, Linehan WM, Klausner RD, Ried T.
    Genes Chromosomes Cancer; 2001 May 01; 31(1):1-9. PubMed ID: 11284029
    [Abstract] [Full Text] [Related]

  • 12. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
    Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U, Zhuang Z.
    Am J Pathol; 1997 Oct 01; 151(4):951-6. PubMed ID: 9327728
    [Abstract] [Full Text] [Related]

  • 13. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
    Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HP, Laidlaw J, Li FP.
    Am J Hum Genet; 1994 Dec 01; 55(6):1092-102. PubMed ID: 7977367
    [Abstract] [Full Text] [Related]

  • 14. Body mass index and von Hippel-Lindau gene mutations in clear-cell renal cancer: Results of the Netherlands Cohort Study on diet and cancer.
    Smits KM, Schouten LJ, Hudak E, Verhage B, van Dijk BA, Hulsbergen-van de Kaa CA, Goldbohm RA, Oosterwijk E, van den Brandt PA.
    Ann Epidemiol; 2010 May 01; 20(5):401-4. PubMed ID: 20382342
    [Abstract] [Full Text] [Related]

  • 15. Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction.
    Zhuang Z, Roth MJ, Emmert-Buck MR, Lubensky IA, Liotta LA, Solomon D.
    Acta Cytol; 1994 May 01; 38(5):671-5. PubMed ID: 8091895
    [Abstract] [Full Text] [Related]

  • 16. Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients.
    Cascón A, Escobar B, Montero-Conde C, Rodríguez-Antona C, Ruiz-Llorente S, Osorio A, Mercadillo F, Letón R, Campos JM, García-Sagredo JM, Benítez J, Malumbres M, Robledo M.
    Hum Mutat; 2007 Jun 01; 28(6):613-21. PubMed ID: 17311301
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal cell carcinoma. Molecular genetics and clinical implications.
    Jennings SB, Gnarra JR, Walther MM, Zbar B, Linehan WM.
    Surg Oncol Clin N Am; 1995 Apr 01; 4(2):219-29. PubMed ID: 7796282
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.